Abstract | OBJECTIVE: SSc is a disease characterized by inflammation and fibrosis. Heme Oxygenase-1 (HO-1) is a haem-degrading enzyme that mediates resolution of inflammation and is induced upon mediators abundantly present in SSc. We aimed to assess whether HO-1 expression/function is disturbed in SSc patients and could therefore be contributing to the ongoing inflammation. METHODS: In total, 92 SSc patients and 48 healthy controls were included. By measuring total bilirubin in plasma in vivo, HO-activity was assessed. HO-1 expression levels were determined with western blot in monocytes before and after induction of HO-1 with cobalt protoporphyrin (CoPP) with or without CXCL4. Monocyte-derived dendritic cells (DCs) were stimulated with several Toll-like receptor (TLR) ligands with or without pre-stimulation with CoPP for 24 h. Cytokine levels were measured in the supernatants using the Luminex Bead Array. RESULTS: SSc patients have lower plasma levels of bilirubin, suggestive of an aberrant HO-1 function. We demonstrated low HO-1 expression in immune cells from SSc patients, whereas induction with CoPP was able to restore HO-1 levels in DCs from SSc patients, almost normalizing the increased TLR response observed in SSc. Co-exposure to CXCL4 completely abrogated CoPP-induced HO-1 expression, suggesting that the high CXCL4 levels present in SSc patients block the normal induction of HO-1 and its function. CONCLUSION: We demonstrate that HO activity in SSc patients is decreased and show its functional consequences. Since CXCL4 blocks the induction of HO-1 expression, neutralization of CXCL4 in SSc patients could have clinical benefits by diminishing overactivation of immune cells and other anti-inflammatory effects of HO-1.
|
Authors | Lenny van Bon, Marta Cossu, Alwin Scharstuhl, Bas W C Pennings, Madelon C Vonk, Hendrik J Vreman, Robert L Lafyatis, Wim van den Berg, Frank A D T G Wagener, Timothy R D J Radstake |
Journal | Rheumatology (Oxford, England)
(Rheumatology (Oxford))
Vol. 55
Issue 11
Pg. 2066-2073
(11 2016)
ISSN: 1462-0332 [Electronic] England |
PMID | 27411481
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | © The Author 2016. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: [email protected]. |
Chemical References |
- Cytokines
- Toll-Like Receptors
- Platelet Factor 4
- Carbon Monoxide
- Heme Oxygenase-1
- Bilirubin
|
Topics |
- Adult
- Bilirubin
(metabolism)
- Carbon Monoxide
(metabolism)
- Case-Control Studies
- Cytokines
(metabolism)
- Dendritic Cells
(metabolism)
- Female
- Fibroblasts
(metabolism)
- Heme Oxygenase-1
(deficiency)
- Humans
- Leukocytes, Mononuclear
(metabolism)
- Male
- Platelet Factor 4
(physiology)
- Scleroderma, Systemic
(enzymology)
- Toll-Like Receptors
(physiology)
|